Healthcare
Robust IPO market bodes well for healthcare sector: IVFA's Siddharth Dhondiyal
The healthcare sector will continue to remain a top priority for sector-agnostic private equity firm India Value Fund Advisors (IVFA), ......
General
Difficult to get PE exits in India? It's a myth, says Renuka Ramnath
Dismissing the perception among a set of investors that India is a difficult market to secure exits from, Renuka Ramnath, ......
General
Multiples PE closes third deal from second fund
Multiples Alternate Asset Management Pvt. Ltd has struck its third deal from its second sector-agnostic fund, a top company executive ......
Healthcare
GSK Velu's family office nears second healthcare deal
The family office of serial healthcare entrepreneur GSK Velu, the founder of medical technology firm Trivitron, is close to striking ......
General
Renuka Ramnath-led Multiples PE's AUM crosses $1 bn post closure of second fund
Indian private equity firm Multiples Alternate Asset Management Pvt. Ltd has wrapped up the fundraising process for its second fund, ......
General
ASK Pravi seeks to wrap up investments from debut fund by 2016-end
ASK Pravi Capital Advisors, a joint venture between ASK Group and Pravi Capital, aims to wrap up investments from its ......
Healthcare
Amanta Healthcare hires banker for fresh funding
Amanta Healthcare, formerly known as Marck Biosciences, has engaged an investment banker for its next round of funding that will ......
Healthcare
TechMed Healthcare gets commitment for fresh funding
TechMed Healthcare and Diagnostics Pvt Ltd, a hospital lab management (HLM) pathology chain, has received commitment for a fresh round ......
Healthcare
Omni Hospitals starts second fundraise round; PE investor eyes debut exit
Hyderabad-based Omni Hospitals, which is backed by private equity firm ASK Pravi Capital Advisors, has initiated a second round of ......
Healthcare
Former Paras Pharma execs' firm buying into Chennai-based wellness startup
Athena Life Sciences Pvt. Ltd, founded by the former top executives of the erstwhile Paras Pharmaceuticals, has agreed to pick ......